DrAlmut Winterstein
DIS PROF
PH-PHARM OUTCOMES & POLICY
GRANTS
- GRANTCardiovascular Safety of Medical Cannabis: Turning Safety Signals into Actionable, Risk-Stratified EvidenceAmerican Heart Association24 Mar 2026 - 31 Mar 2029
- GRANTGraduate Program Work Plan #5Merck and Company Inc14 Jan 2026 - 31 Oct 2026
- GRANTA Post-Marketing Study to Evaluate the Safety of ABRYSVO™ on the Risk of Guillain-Barré Syndrome (GBS) in PregnancyPfizer Inc3 Mar 2025 - 30 Jun 2026
- GRANTGraduate Program Work Plan #4Merck and Company Inc15 Nov 2024 - 31 Dec 2025
- GRANTSurveillance of Muscular DystrophiesCenters for Disease Control and Prevention5 Aug 2024 - 31 Aug 2028
- GRANTExploring the Interplay between Social Determinants of Health and Multimorbidity in Veterans: A Microsimulation Modeling ApproachPharm Research and Mfrs of American Foundation1 Mar 2024 - 31 Aug 2025
- GRANTPain, Multimorbidity, Opioid-Drug Interactions and Risk for Opioid Use Disorder or Overdose in Older AdultsAgency for Healthcare Research and Quality7 Aug 2023 - 31 Jan 2026
- GRANTGraduate Program Work Plan #3Merck and Company Inc17 Jul 2023 - 30 Jun 2024
- GRANTBayesian machine learning for complex missing data and causal inference with a focus on cardiovascular and obesity studiesNational Institute of Health Nhlbi23 Feb 2023 - 28 Feb 2027
- GRANTOpioid Prescribing Practices and Health Outcomes among Patients with Alzheimer’s Disease and Related DementiaNational Institute of Health Nia20 Feb 2023 - 31 May 2026
- GRANTBig data approaches for safe therapeutics in healthy pregnancies (BOOST-HP)National Institute of Health Nichd14 Feb 2023 - 30 Apr 2027
- GRANTMedical Literature and Data on Cannabis UseUS Food and Drug Administration27 Jan 2023 - 15 Aug 2023
- GRANTCharacterizing efficacy and safety of hormonal contraceptives by combining pharmacometrics and RWEBill & Melinda Gates Foundation14 Nov 2022 - 31 Oct 2026
- GRANTEvaluation of Emerging Infections during Pregnancy and their Prevention and Treatment using Enhanced and Diverse Mother-Baby CohortsCenters for Disease Control and Prevention30 Sep 2022 - 28 Mar 2025
- GRANTBuilding Quality Improvement in the use of New Glucose-lowering Drugs (GLDs) through Individualized Drug Value Assessment in People with DiabetesNational Institute of Health Niddk19 Jul 2022 - 1 Dec 2025
- GRANTMerck Graduate Program Work Plan #2Merck and Company Inc9 Mar 2022 - 15 Dec 2022
- GRANTTeratogenic Risk Impact and Mitigation (TRIM): An Evidence-based Decision FrameworkUS Food and Drug Administration29 Sep 2021 - 31 Mar 2025
- GRANTPreventing the Calcium Channel Blocker – Lower Extremity Edema – Loop Diuretic Prescribing Cascade in Older AdultsNational Institute of Health Nia29 Apr 2021 - 20 Oct 2022
- GRANTSentinel 2014: TreeScan in Pregnancy – Maternal OutcomesUS Food and Drug Administration26 Jan 2021 - 31 Dec 2022
- GRANTPrecision antiplatelet therapy after percutaneous coronary interventionNational Institute of Health Nhlbi15 Jun 2020 - 30 Jun 2026
- GRANTEpidemiology and cost of RSV infections in infants and toddlersMerck and Company Inc14 May 2020 - 30 Sep 2022
- GRANTBD&L Discovery Transactions Work PlanMerck and Company Inc16 Dec 2019 - 15 Dec 2021
- GRANTConsortium for Medical Marijuana Clinical Outcomes ResearchFlorida Legislature17 Jul 2019 - 31 Dec 2020
- GRANTObservational External Comparator Cohorts as Controls for Long-Term Uncontrolled Extensions to RCTsInternational Society for Pharmacoepidemiology21 May 2019 - 13 Sep 2019
- GRANTDeveloping a Real-Time Trajectory Tool to Identify Potentially Unsafe Concurrent Opioid and Benzodiazepine Use among Older AdultsNational Institute of Health Nia30 Apr 2019 - 31 Jan 2022